ASAP Act
Sponsored By: Senator Collins, Susan M. [R-ME]
Introduced
Summary
Creates a Medicare coverage pathway for Alzheimer’s early detection screening tests. This bill would define which tests qualify and tie Medicare coverage and payment to FDA clearance or approval for tests furnished on or after January 1, 2028.
Show full summary
- Families and Medicare beneficiaries: Could gain covered access to tests meant to detect pre-symptomatic and early-stage Alzheimer’s disease and related dementias, with coverage tied to tests furnished on or after Jan 1, 2028.
- Test developers and labs: Would need FDA clearance or approval under pathways such as 510(k), 513(f)(2), or 515 to qualify. The bill explicitly allows a wide set of test types, including genomic sequencing blood tests, single-analyte tests, cell-free nucleic acids, multiplex panels, whole genome or exome sequencing, protein expression assays, and medical imaging based on biospecimens.
- Medicare program and providers: Adds a new covered category to the Social Security Act and updates Medicare payment rules so qualifying ADRD early detection screening tests are eligible for Medicare payment.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Medicare coverage for early dementia tests
If enacted, Medicare would cover certain early Alzheimer's and dementia screening tests starting on or after January 1, 2028. Tests would qualify only if cleared under FDA 510(k), classified under 513(f)(2), or approved under 515. Covered tests would include genomic sequencing blood or blood-product tests and other equivalent tests based on blood, tissue, urine, or other biospecimens. The bill would add these tests to Medicare payment rules, which could lower out-of-pocket costs for beneficiaries who receive them.
Sponsors & CoSponsors
Sponsor
Collins, Susan M. [R-ME]
ME • R
Cosponsors
Sen. Cortez Masto, Catherine [D-NV]
NV • D
Sponsored 11/20/2025
Shelley Capito
WV • R
Sponsored 11/20/2025
Sen. Warner, Mark R. [D-VA]
VA • D
Sponsored 11/20/2025
Sen. Banks, Jim [R-IN]
IN • R
Sponsored 12/10/2025
Sen. Lankford, James [R-OK]
OK • R
Sponsored 12/16/2025
Sen. Kennedy, John [R-LA]
LA • R
Sponsored 1/12/2026
Sen. Duckworth, Tammy [D-IL]
IL • D
Sponsored 1/12/2026
Sen. Booker, Cory A. [D-NJ]
NJ • D
Sponsored 1/27/2026
Sen. Moran, Jerry [R-KS]
KS • R
Sponsored 1/28/2026
Sen. Tillis, Thomas [R-NC]
NC • R
Sponsored 2/11/2026
Sen. Daines, Steve [R-MT]
MT • R
Sponsored 2/11/2026
Sen. Fischer, Deb [R-NE]
NE • R
Sponsored 2/12/2026
Sen. Murkowski, Lisa [R-AK]
AK • R
Sponsored 2/24/2026
Sen. Scott, Rick [R-FL]
FL • R
Sponsored 2/24/2026
Sen. Cramer, Kevin [R-ND]
ND • R
Sponsored 2/26/2026
Cindy Hyde-Smith
MS • R
Sponsored 3/4/2026
Mike Rounds
SD • R
Sponsored 3/4/2026
Katie Britt
AL • R
Sponsored 3/10/2026
Amy Klobuchar
MN • D
Sponsored 4/21/2026
Sen. Coons, Christopher A. [D-DE]
DE • D
Sponsored 5/11/2026
Sen. Gillibrand, Kirsten E. [D-NY]
NY • D
Sponsored 5/11/2026
Alan Armstrong
OK • R
Sponsored 5/12/2026
Roger Wicker
MS • R
Sponsored 5/14/2026
Sen. Kelly, Mark [D-AZ]
AZ • D
Sponsored 5/14/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov